Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Panelists discuss how, cemiplimab, a PD-1 inhibitor, has shown promise as a second-line therapy for advanced NSCLC after ...

Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people ...

Panelists discuss how, as new data on cemiplimab and other checkpoint inhibitors emerge, the treatment pathway for cancers ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the ...

The analysis from the Urban Institute breaks down projected coverage losses across the 40 Medicaid expansion states, where ...

A trial found magnetic resonance imaging correlated with physical function tests in patients with Duchenne muscular dystrophy ...

Maureen Corcoran, director of the Ohio Department of Medicaid, believes the work requirement policy can be both a financial ...

In this first part of a two-part video series, Jennifer Haley, principal research associate of the Health Policy Division at ...

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in ...

The difference between specialty drugs and traditional drugs and how each have vied for market competition, according to Jeff ...